China National Accord Medicines Corporation Ltd.

SZSE:000028 Stock Report

Market Cap: CN¥13.4b

China National Accord Medicines Balance Sheet Health

Financial Health criteria checks 5/6

China National Accord Medicines has a total shareholder equity of CN¥21.7B and total debt of CN¥4.3B, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are CN¥52.0B and CN¥30.3B respectively. China National Accord Medicines's EBIT is CN¥1.9B making its interest coverage ratio -29. It has cash and short-term investments of CN¥5.4B.

Key information

19.9%

Debt to equity ratio

CN¥4.30b

Debt

Interest coverage ratio-29x
CashCN¥5.43b
EquityCN¥21.65b
Total liabilitiesCN¥30.33b
Total assetsCN¥51.98b

Recent financial health updates

Recent updates

Here's Why China National Accord Medicines (SZSE:000028) Can Manage Its Debt Responsibly

Jan 22
Here's Why China National Accord Medicines (SZSE:000028) Can Manage Its Debt Responsibly

Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

Nov 18
Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 30
China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

Oct 10
China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Aug 13
China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Jul 12
Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Jun 12
Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

May 12
Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Financial Position Analysis

Short Term Liabilities: 000028's short term assets (CN¥40.7B) exceed its short term liabilities (CN¥28.1B).

Long Term Liabilities: 000028's short term assets (CN¥40.7B) exceed its long term liabilities (CN¥2.2B).


Debt to Equity History and Analysis

Debt Level: 000028 has more cash than its total debt.

Reducing Debt: 000028's debt to equity ratio has increased from 16.2% to 19.9% over the past 5 years.

Debt Coverage: 000028's debt is well covered by operating cash flow (64%).

Interest Coverage: 000028 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 04:11
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

China National Accord Medicines Corporation Ltd. is covered by 25 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lei TianAJ Securities Co., Ltd
Shuchang LiuChangjiang Securities Co. LTD.
Yanyin ZhuChina International Capital Corporation Limited